Utility of Continuous Glucose Monitoring in Type 1 and Type 2 Diabetes.
A consensus conference of the American Association of Clinical Endocrinologists and American College of Endocrinology held in February 2016 advocated expanding the use of continuous glucose monitoring (CGM) in the management of diabetes. Based on the data described in this paper, CGM use is shown to improve glucose control and reduce hypoglycemic events, and therefore has the potential to reduce the risk of acute and chronic complications of diabetes. Likely, all of the above would not only improve the quality of life and life expectancy of people with diabetes, but would also have a positive impact on health-related cost.
Joslin Diabetes Center, Adult Section, One Joslin Place, Boston, MA 02215, USA. Electronic address: elena.toschi@joslin.harvard.edu.
Elena
E
Toschi
Joslin Diabetes Center, Adult Section, One Joslin Place, Boston, MA 02215, USA.
Howard
H
Wolpert
D001786:Blood Glucose / Q000032:analysis; D015190:Blood Glucose Self-Monitoring; D003922:Diabetes Mellitus, Type 1 / Q000097:blood*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood*; D006801:Humans; D011788:Quality of Life
D001786:Blood Glucose
Continuous glucose monitoring; Technology; Type 1 diabetes mellitus; Type 2 diabetes mellitus